Viagra was approved by the U.S. Food and Drug Administration 27 years ago. Experts say it immediately changed the way we talk ...
Added Carolyn Penot, Director of Operational Marketing at Aptar Pharma, “RDD Europe 2025 is a must-attend event, and this year’s Knowledge Spaces will represent the latest thinking in nasal ...
Analysts expect that West Pharmaceutical Services, Inc. will post 6.62 EPS for the current year. The business also recently declared a quarterly dividend, which will be paid on Wednesday ...
The 19th Amendment, which gave women the right to vote, was passed more than 100 years ago, although it would be many decades before all women could vote. The women's rights movement reached a ...
and SUZHOU, China, March 12, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ ... today announced that it will release full year 2024 financial results, and provide an update on recent ...
THE PHILIPPINE pharmaceutical industry is targeting at least 9% growth this year amid the implementation of the universal healthcare law, an industry group said. “The growth is estimated at 9%. The ...
PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq ... today announced financial results for the fourth quarter and full year ended December 31, 2024, and provided an overview of ...
We recently published an article titled Why These 15 Large-Cap Stocks Are Plunging So Far In 2025. In this article, we are going to take a look at where West Pharmaceutical Services, Inc. (NYSE:WST) ...
In this article, we are going to take a look at where West Pharmaceutical Services ... performing large-cap stocks ($10 billion to $100 billion) year-to-date. I will also mention the number ...
1 The presentation marks the third consecutive year that LEO Pharma has presented late-breaking data at AAD. Alongside this presentation, new systemic exposure data has also been shared for ...
Walgreens Boots Alliance will be taken private by Sycamore Partners for $10 billion, the buyout firm said on Thursday, closing out nearly a century of trading on public markets for the U.S. pharmacy ...